Table 5.
Regulation | miRNA | Linear fold change | P value |
---|---|---|---|
Upregulated in R-t 15 | hsa-miR-126-3p | 3.30 | 2.05E − 02 |
hsa-miR-30c-5p | 3.44 | 4.71E − 03 | |
hsa-miR-331-3p∗ | 163.08 | 3.12E − 02 | |
| |||
Downregulated in R-t 15 | hsa-miR-1208 | 0.53 | 3.55E − 02 |
hsa-miR-1226-5p | 0.42 | 2.78E − 02 | |
hsa-miR-1260a | 0.35 | 4.07E − 02 | |
hsa-miR-1275 | 0.24 | 1.93E − 03 | |
hsa-miR-1291 | 0.15 | 3.98E − 02 | |
hsa-miR-1300 | 0.29 | 2.08E − 02 | |
hsa-miR-16-5p∗ | 0.27 | 2.23E − 02 | |
hsa-miR-1825 | 0.50 | 4.13E − 02 | |
hsa-miR-215-5p | 0.05 | 3.76E − 02 | |
hsa-miR-222-5p | 0.26 | 3.66E − 02 | |
hsa-miR-23a-5p∗ | 0.18 | 4.28E − 03 | |
hsa-miR-25-5p∗ | 0.03 | 3.26E − 02 | |
hsa-miR-451a∗ | 0.35 | 9.49E − 03 | |
hsa-miR-550a-3p | 0.34 | 1.27E − 02 | |
hsa-miR-605-5p | 0.19 | 1.34E − 02 | |
hsa-miR-628-5p | 0.00 | 3.07E − 02 | |
hsa-miR-720 | 0.41 | 5.80E − 03 | |
hsa-miR-765 | 0.01 | 4.16E − 02 |
∗Hemolysis-susceptible miRNAs as reported in Kirschner et al. [21].